Project Grant R21OD037741
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,359,000.00 to Baylor College of Medicine to conduct research on age-associated cellular and molecular adaptations that enable whole-organism rejuvenation in the highly regenerative flatworm Schmidtea mediterranea. The research aims to (1) determine how age-associated damage manifests in asexual planaria throughout their lifecycle...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Boston Children's Hospital $1.87 million through the Aging Research program (CFDA 93.866) to conduct a four-year research project (August 2025 – July 2029) investigating the genetics of exceptional longevity and cellular resilience mechanisms. The primary deliverable is scientific research examining the genome of the ocean quahog (Arctica islandica), the world's longest-lived animal with documented lifespans...
- This $1,044,855 Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund Nemalife Inc. to deliver high-throughput testing of anti-aging and FDA-approved drugs in genetically diverse invertebrate Alzheimer's disease models. Under the Aging Research program (CFDA 93.866), the awardee will screen 300 anti-aging compounds and 200 FDA drugs to identify candidates that improve neuronal aging and protect against protein misfolding diseases...
- The National Institutes of Health (NIH) Office of the Director awarded a $1,404,000 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Regents of the University of Michigan. The grant, titled "Turning Back Biological Clock: Mechanisms of Age Reversal in a Whole Organism," aims to investigate the molecular and cellular mechanisms underlying age reversal in the planarian S. mediterranea. Specifically, the research will examine two potential mechanisms for...
- This Project Grant from the National Science Foundation, under the Biological Sciences program (CFDA 47.074), provides $240,000 to fund research investigating gene regulatory network evolution across 13 species of roundworms. The fellowship award supports a postdoctoral researcher from June 1, 2023 to May 31, 2026. The researcher will use single-cell sequencing to build molecular atlases of embryonic development for each roundworm species, comparing gene expression patterns across tissues and...
- This $2,624,970 federal Project Grant, awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), aims to construct the first-ever foundational in silico (computational) model of whole-embryo mouse embryogenesis. The project will leverage cutting-edge sequencing technology and machine learning techniques to establish a large-scale 3D multi-omics cell atlas of mouse embryogenesis from embryonic day 6.5 to 16.5, involving a total of 50 million...
- Grant Award Summary Baylor College of Medicine received a $440,000 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to conduct exploratory research investigating epigenetic drivers of lifespan heterogeneity in budding yeast. The award, effective May 1, 2026 through April 30, 2028, supports the development of yeast single-cell aging atlases using unbiased single-cell transcriptomic and epigenomic analyses. The project will generate...
- This Project Grant award, funded by the National Science Foundation (NSF) under the Biological Sciences program (CFDA 47.074), supports research on how the hormone aldosterone regulates amphibian metamorphosis from aquatic to terrestrial forms. The $629,995 award to the University of Cincinnati, with a performance period from September 2024 to August 2027, aims to reveal aldosterone's precise role in frog development by measuring corticosteroid levels, comparing wild-type and mutant tadpoles,...
- Duke University received a $1,019,484.58 Project Grant award from the National Institutes of Health's National Institute on Aging under the Aging Research program (CFDA 93.866) for the period September 1, 2021 through May 31, 2022. The award will support research using the nematode C. elegans as a model organism to study aging-associated neurodegeneration at the molecular level, with the goals of uncovering novel mechanisms underlying this process and establishing C. elegans neurons as a...
- This federal Project Grant award for $169,000.00, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports the development of a single-cell reference atlas of axolotl embryogenesis. The overarching goal is to elucidate the fundamental biological processes required for limb regeneration, with the aim of informing future regenerative medicine strategies for human limb injuries...
GENETICALLY ENABLING HYDRA OLIGACTIS FOR COMPARATIVE STUDIES IN DEVELOPMENT, REGENERATION AND AGING. - PROJECT SUMMARY THE SMALL FRESHWATER CNIDARIAN HYDRA HAS PLAYED A CRUCIAL ROLE IN SEVERAL SCIENTIFIC BREAKTHROUGHS, MOST NOTABLY BEING THE FIRST ANIMAL WHERE REGENERATION WAS DISCOVERED IN 1744. OVER THE YEARS, DIFFERENT HYDRA SPECIES CONTRIBUTED TO FUNDAMENTAL FINDINGS, BUT HYDRA VULGARIS HAS BECOME THE STANDARD "HYDRA MODEL" IN MODERN MOLECULAR RESEARCH. WITH A CHROMOSOME-LEVEL GENOME ASSEMBLY AND TOOLS TO TEST GENE FUNCTION, H. VULGARIS IS A PRIME MODEL FOR DEVELOPMENTAL AND REGENERATIVE BIOLOGY BUT IS ALSO AN EMERGING MODEL IN VARIOUS FIELDS INCLUDING NEUROSCIENCE AND MICROBIOME RESEARCH. IN CONTRAST, HYDRA OLIGACTIS, ANOTHER HYDRA SPECIES, REMAINS UNDERUTILIZED DESPITE ITS BIOLOGICALLY RELEVANT DISTINCT FEATURES. UNLIKE H. VULGARIS, H. OLIGACTIS EXHIBITS DEFICIENCIES IN REGENERATING ITS ABORAL END AND UNDERGOES SENESCENCE AND DEATH UPON GAMETE PRODUCTION. THE SHARP CONTRASTS BETWEEN THESE CLOSELY RELATED SPECIES OFFER A UNIQUE COMPARATIVE PLATFORM FOR EXPLORING MOLECULAR MECHANISMS IN REGENERATION AND AGING. DESPITE BEING BEHIND IN TOOLS AND RESOURCES, H. OLIGACTIS CAN BE RELIABLY CULTURED, MAKING IT A PROMISING CANDIDATE FOR FUNCTIONAL STUDIES. COMPLETION OF THE PROPOSED AIMS WILL BRIDGE THE GAP BETWEEN THE TWO SPECIES: 1. BUILD GENOMIC AND TRANSCRIPTOMIC RESOURCES: DEVELOP A CHROMOSOME-SCALE GENOME ASSEMBLY WITH GENE REGULATORY ANNOTATIONS, AND A SINGLE-CELL EXPRESSION ATLAS FOR H. OLIGACTIS, PARALLELING THE RESOURCES AVAILABLE FOR H. VULGARIS. 2. IMPLEMENT TRANSGENESIS AND SIRNA KNOCKDOWN: ESTABLISH TRANSGENESIS IN H. OLIGACTIS AND CREATE TRANSGENIC LINES THAT EXPRESS FLUORESCENT PROTEINS IN SPECIFIC LINEAGES. THESE LINES WILL ENABLE THE OPTIMIZATION OF GENE KNOCKDOWN THROUGH SIRNA ELECTROPORATION. 3. DEVELOP CRISPR GENE EDITING: UTILIZE THE INDUCIBLE EGG PRODUCTION IN H. OLIGACTIS TO TROUBLESHOOT CRISPR-CAS9 MEDIATED GENE EDITING. THE IMMEDIATE GOAL IS TO TAG THE ENDOGENOUS EF1-ALPHA GENE, A STRATEGY THAT WILL INFORM FUTURE GENE EDITING ATTEMPTS IN BOTH H. OLIGACTIS AND H. VULGARIS. THE COMPLETION OF THESE AIMS WILL EQUIP H. OLIGACTIS WITH TOOLS AND RESOURCES COMPARABLE TO H. VULGARIS, ENABLING FUNCTIONAL STUDIES AND COMPARATIVE ANALYSES. THIS COMPARATIVE APPROACH HOLDS POTENTIAL IMPLICATIONS FOR VARIOUS SCIENTIFIC FIELDS, INCLUDING DEVELOPMENTAL AND REGENERATIVE BIOLOGY, AGING, NEUROSCIENCE, MICROBIOME RESEARCH, AND BIOPHYSICS. THIS PROJECT IS THEREFORE HIGHLY RESPONSIVE TO THE FOA (PAR-21-167), WHICH CALLS FOR THE DEVELOPMENT AND IMPROVEMENT OF ANIMAL MODELS THAT ARE RELEVANT TO MULTIPLE NIH INSTITUTES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $201.3k | 8/11/25 | ||
| Not listed | $241.5k | 7/11/24 |